Trials / Recruiting
RecruitingNCT06583148
A Smoke-Free Home Intervention in Tribal Communities
Assessing the Effectiveness of a Smoke-Free Home Program in Tribal Communities
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 575 (estimated)
- Sponsor
- Emory University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This clinical trial evaluates a smoke-free home intervention for reducing exposure to secondhand smoke from commercial tobacco in homes of participants who live in rural tribal communities. Smoke-free homes are an innovative and relatively untapped strategy for cancer prevention in rural tribal communities. Smoke-free policies, including those that target homes, can reduce exposure to secondhand smoke and support smoking cessation. Rural and racial/ethnic inequities intersect to increase tobacco-related harms among Indigenous populations. A smoke-free home program may improve the health of the household as well as impact smoking behavior among the family unit by reducing secondhand smoke exposure.
Detailed description
PRIMARY OBJECTIVE: I. To assess the effectiveness of a smoke-free homes intervention for tribal communities. OUTLINE: Participants are randomized to 1 of 2 groups. GROUP I: Participants receive the smoke-free home program, consisting of mailed educational information about smoke-free homes at enrollment and in weeks 4 and 6, and attend one coaching call in week 2. GROUP II: Participants receive usual care on study. Participants may optionally receive the smoke-free home program following the 6 months follow-up. After completion of study intervention, participants are followed up at 3 and 6 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Best Practice | Receive usual care |
| BEHAVIORAL | Smoking Cessation Intervention | Receive the smoke-free home program |
| OTHER | Survey Administration | Ancillary studies |
Timeline
- Start date
- 2024-11-15
- Primary completion
- 2028-01-31
- Completion
- 2029-01-31
- First posted
- 2024-09-03
- Last updated
- 2025-12-08
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06583148. Inclusion in this directory is not an endorsement.